or Try an Advanced Search...

    Breast And Ovarian Cancer Stocks List

    Symbol Grade Name % Change
    MRKR D Marker Therapeutics, Inc. -1.26
    MYGN F Myriad Genetics, Inc. -0.52
    PSTV F Plus Therapeutics, Inc. 0.84
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Cancer Ovarian Cancer Clinical Medicine Disease Medicine Biomarkers Biotechnology Blastoma Cancer Immunotherapy Cancer Treatment Cell Therapy Chemical Pathology Colorectal Cancer Companion Diagnostic Diagnostic Services Diagnostic Tests Docetaxel Doxorubicin Drugs Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Breast And Ovarian Cancer stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 2.8
    PINK D Simplify Health Care ETF 1.98
    RJMG A FT Raymond James Multicap Growth Equity ETF 1.74
    PBE D PowerShares Dynamic Biotech & Genome 1.61
    WDNA D WisdomTree BioRevolution Fund 1.02
    View all Breast And Ovarian Cancer ETFs...
    Compare ETFs
    Compare GNOM to PBE Compare PBE to WDNA Compare PINK to RJMG

        Breast And Ovarian Cancer Stocks Recent News

        Date Stock Title
        Nov 20 MYGN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
        Nov 19 MYGN Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
        Nov 19 MYGN Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley
        Nov 17 MRKR Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
        Nov 15 PSTV Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
        Nov 14 MRKR Marker Therapeutics GAAP EPS of -$0.26, revenue of $1.93M
        Nov 14 MRKR Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
        Nov 14 PSTV Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M
        Nov 14 PSTV Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Cancer Ovarian Cancer Clinical Medicine Disease Medicine Biomarkers Biotechnology Blastoma Cancer Immunotherapy Cancer Treatment Cell Therapy Chemical Pathology Colorectal Cancer Companion Diagnostic Diagnostic Services Diagnostic Tests Docetaxel Doxorubicin Drugs Genetics
        Breast And Ovarian Cancer

        Breast and ovarian cancer are two types of cancer that affect women. Breast cancer is the most common type of cancer in women, and it occurs when cells in the breast tissue divide and grow abnormally. Ovarian cancer is a less common type of cancer, and it occurs when cells in the ovaries divide and grow abnormally. Both types of cancer can be treated with surgery, chemotherapy, radiation, and other treatments.

        Browse All Tags